Technical Analysis for AVGR - Avinger, Inc.

Grade Last Price % Change Price Change
grade C 1.03 -1.90% -0.02
AVGR closed down 1.9 percent on Tuesday, March 19, 2019, on 2.05 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical AVGR trend table...

Date Alert Name Type % Chg
Mar 19 New Uptrend Bullish 0.00%
Mar 19 Calm After Storm Range Contraction 0.00%
Mar 19 Parabolic Rise Strength 0.00%
Mar 19 Upper Bollinger Band Walk Strength 0.00%
Mar 19 Inside Day Range Contraction 0.00%
Mar 19 Wide Bands Range Expansion 0.00%
Mar 19 Above Upper BB Strength 0.00%
Mar 19 Overbought Stochastic Strength 0.00%
Mar 19 Upper Bollinger Band Touch Strength 0.00%
Mar 18 Crossed Above 200 DMA Bullish -1.90%

Older signals for AVGR ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Avinger, Inc., a medical device company, designs, manufactures, and sells image-guided, catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD). It offers Lightbox, an imaging console, which enables the use of lumivascular catheters during PAD procedures; Ocelot, a chronic total occlusion (CTO) crossing catheter, which allows physicians to see the inside of an artery during a CTO crossing procedure; Ocelot PIXL, a lower profile CTO-crossing device for below-the-knee arteries; and Ocelot MVRX, a device which offers a tip design for above-the-knee arteries. The company also provides Wildcat, a catheter that facilitates the intraluminal placement of conventional guidewires beyond stenotic lesions in the peripheral vasculature prior to further percutaneous intervention; and Kittycat 2, a catheter that facilitate the intraluminal placement of conventional guidewires beyond stenotic lesions in the peripheral vasculature prior to further percutaneous intervention. The company offers its products to interventional cardiologists, vascular surgeons, and interventional radiologists directly in the United States and Europe. Avinger, Inc. was founded in 2007 and is headquartered in Redwood City, California.
Medicine Medical Specialties Clinical Medicine Imaging Medical Imaging Catheters Catheter Interventional Radiology Interventional Cardiology Cordis Peripheral Arterial Disease Percutaneous
Is AVGR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 2.44
52 Week Low 0.18
Average Volume 4,010,417
200-Day Moving Average 0.9172
50-Day Moving Average 0.4688
20-Day Moving Average 0.6517
10-Day Moving Average 0.7471
Average True Range 0.0813
ADX 26.95
+DI 48.7985
-DI 12.1292
Chandelier Exit (Long, 3 ATRs ) 0.8561
Chandelier Exit (Short, 3 ATRs ) 0.6489
Upper Bollinger Band 0.9836
Lower Bollinger Band 0.3198
Percent B (%b) 1.07
BandWidth 101.856683
MACD Line 0.1302
MACD Signal Line 0.0915
MACD Histogram 0.0387
Fundamentals Value
Market Cap 24.63 Million
Num Shares 23.9 Million
EPS -2.46
Price-to-Earnings (P/E) Ratio -0.42
Price-to-Sales 0.50
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.17
Resistance 3 (R3) 1.16 1.12 1.14
Resistance 2 (R2) 1.12 1.08 1.12 1.13
Resistance 1 (R1) 1.07 1.06 1.08 1.08 1.13
Pivot Point 1.03 1.03 1.03 1.03 1.03
Support 1 (S1) 0.98 0.99 0.99 0.99 0.93
Support 2 (S2) 0.94 0.97 0.94 0.93
Support 3 (S3) 0.89 0.94 0.92
Support 4 (S4) 0.90